PubMed HealthSearch

PubMed · 9444382

Sinusonasal polyposis.

Abstract

The histological aspects and general disorders related to nasal polyps are reviewed. The origin and physiopathology of nasal polyposis are discussed. The influence of morphology in polyp classification and the contribution of glycohistochemistry are emphasized.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S Hassid. 1997. Sinusonasal polyposis.. https://pubmed.ncbi.nlm.nih.gov/9444382/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effect of a Staphylococcus epidermidis-extracted slime factor on human natural killer cell activity.

A slime factor produced by Staphylococcus epidermidis was a complex glycoconjugate extracted by the phenol extraction method. The potential stimulatory or inhibitory capacity of the phenol-extracted slime (PES) was tested on human natural killer cell cytotoxic activity. Various concentrations of the PES preparation were incubated with the effector cells 30 min before and during the assay period. The PES factor inhibited natural killer cell cytotoxic activity at a concentration of 250 micrograms/ml and at higher concentrations (p < 0.05). The inhibition of natural killer cell cytotoxic activity may probably be related to the complex composition of the slime substance.

Glycoconjugates

Syntheses and some applications of chemically defined multivalent glycoconjugates.

Classical multivalent neoglycoproteins have been widely used to study a great number of carbohydrate-protein interactions. The synthesis of other neoglycoconjugates with various shapes, valencies, and conformations has reached considerable levels of sophistication and holds promise as a new tool for glycobiology and biomedical applications. Within the last few years, advances have been made towards both the syntheses and understanding of the antigenic properties of water-soluble glycopolymers. Some of these glycopolymers are finding applications as inhibitors of microbial adhesins and as carriers for drug delivery to specific cells. Novel dendritic carbohydrate structures are emerging as potent ligands for carbohydrate-binding proteins.

Glycoconjugates